CTEV vs EVH
CTEV: Claritev leverages decades of claims data and AI-driven analytics to provide payment integrity, network management, and cost-transparency solutions that reduce healthcare spending for payers and employers. EVH: Evolent Health manages complex specialty care, such as oncology and cardiology, using clinical technology and provider networks to help health plans lower costs and improve health outcomes.
Side-by-side fundamentals
| Metric | CTEV | EVH | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $24.33 | $3.96 | |
| Market cap | $412M | $448M | |
| Net margin FY2025, SEC XBRL | -29.4% | -28.5% | EVH higher |
| Operating margin FY2025, SEC XBRL | +3.0% | -21.9% | CTEV higher |
| ROE FY2025, SEC XBRL | n/a | -128.7% | |
| ROA FY2025, SEC XBRL | -5.8% | -28.1% | CTEV higher |
| Debt / equity as of 2026-09-03 | 311.26 | 2.52 | EVH lower |
| Revenue growth (YoY) as of 2026-09-03 | +5.5% | -4.5% | CTEV higher |
| Revenue CAGR (3y) SEC XBRL | -3.7% | +11.5% | EVH higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 1.29 | 0.71 | |
| 1-year return as of 2026-10-08 close | -57.6% | -50.8% | EVH higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.